Organon to File Q3 2026 10-Q; Expects No Milestone Expense
Organon says it will release Q3 2026 results through its Form 10-Q and a same-day Form 8-K with non-GAAP reconciliations. The company does not expect Q3 2026 milestone expense and has suspended quarterly earnings calls during the pending Sun Pharma acquisition.